Insilico Medicine and Servier achieve first milestone in AI-driven R&D collaboration, triggering an undisclosed milestone payment
Business Announcement
Updates every hour. Last Updated: 24-Oct-2026 05:16 ET (24-Oct-2026 09:16 GMT/UTC)
Insilico Medicine (“Insilico”, HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced that the company has achieved the early drug discovery milestone in its multi-year AI-driven drug discovery collaboration with Servier, an independent international pharmaceutical group governed by a foundation.
USC researchers studying human brain tissue found an association between abnormal immature astroglia, cells that play a supporting role in brain function, and lower reasoning ability in older adults with epilepsy.
A Concordia-led study suggests that childhood home environments may influence long-term mental health in children of parents with bipolar disorder. Researchers found that less structured, predictable family environments were associated with changes in cortisol responses and more depression and anxiety symptoms in young adulthood, highlighting the potential value of family-based prevention.
Many older patients with heart failure survive hospitalization but lose independence within a year after discharge. Researchers from Japan developed a machine learning model using physical function and clinical data to predict this risk. The model outperformed a standard frailty screening tool and identified a group with low mortality but high functional decline. The findings could help clinicians prioritize rehabilitation and discharge support for patients most likely to lose independence after discharge and improve care.